TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Lower urinary tract dysfunction at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Recurrent urinary tract infections
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage compliant in the use of antiplatelet therapy at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of procedure score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: health state utility values
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical symptoms of overdrainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average HbA(1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: body fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HOMA-Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: area under the curve for insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Motor blockade intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SVV deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with perioperative management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative phlebitis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: improvement of motor functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative peripheral refractive error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: awareness of community services for dating violence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: conflict management skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: dating violence norms
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: mean sensitivity for myopia screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean specificity for myopia screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: net benefits of Strategy IV for myopia screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 5-year renal survival rate
Endpoint domain: Mortality/survival
Primary endpoint: probability of achieving complete remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for care and handling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subcutaneous fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical and sigmoidoscopic remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawals due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: HDL3-cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma apolipoprotein A-I concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum carotenoids levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expressions of inflammatory markers (CD3, CD68, ICAM‐1, MMP9, CD40L, tenascin‐C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lipid content of the plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Interstitial collagen in tissue sections of plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score of nasal obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of fetal reverse
Endpoint domain: Mortality/survival
Primary endpoint: systemic vascular resistance index (SVRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Histologic markers of NAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score of headache and nasal obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mucosa edema of nasal cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing rates and number of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in general subscale of the MFSI-SF
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Coronary artery calcium score (CACS) progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MIF recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOR recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preparedness and competence for caregiving
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of POST at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exit task difficulty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exit task impedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total exit times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective feelings of hunger
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Development of high-grade dysplasia (HGD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of neurological events
Endpoint domain: Adverse events/effects
Primary endpoint: HCV RNA absence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rectus femoris activity increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Semitendinosus activity decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bicep femoris activity decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fall in VMCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function (latency of P300 evoked potentials)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CD8+ T‐cell interferon‐γ secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of extracellular vesicles bearing the B‐cell marker CD19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma endothelial growth factor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the PhysioDirect service
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Faster access to physiotherapy advice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Referral to falls services
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambulance job cycle time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Visible nigral area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Substantia nigra/midbrain area ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lateral/medial pixel-intensity ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Potassium excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Satisfaction with primary care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PACIC scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Trust in VA provider
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: depression score on Depression Anxiety Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive performance in working memory test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive performance in selective attention test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: hip abduction strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: hip external rotation strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Balance Error Scoring System total errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stimulation ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake from RUTF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NEI-VFQ-25 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Phagocytosis activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Polymorphonuclear burst activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Freedom from arrhythmia recurrence
Endpoint domain: Mortality/survival
Primary endpoint: EHRA score improvement
Endpoint domain: Life impact
Endpoint subdomain: Symptom severity
Primary endpoint: EQ5D-5L global score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Retention of motor skill
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post-treatment levels of TNF-related cytokines and TNF-receptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean NHS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of photophobia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Observation Scales (DOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ophthalmic success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: cesarean delivery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Student satisfaction with TBL sessions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Student engagement levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of agitation following cessation of sedation
Endpoint domain: Adverse events/effects
Primary endpoint: ICU duration
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: dysphoria
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: dexamphetamine-like effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of BPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: SBP, DBP and HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rates of adverse effect (nausea and vomiting)
Endpoint domain: Adverse events/effects
Primary endpoint: Preference for banana-flavored suspension vs lemon-flavored sachet in children aged 4 to 7 years
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for banana-flavored suspension vs lemon-flavored sachet in children aged 8 to 11 years
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Platelet aggregation to ADP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Expression of GP IIb/IIIa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of low response to aspirin
Endpoint domain: Adverse events/effects
Primary endpoint: stone-free rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prolonged JTc interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early weaning before 26 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language development status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gesell Child Development Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin D and calcium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum concentration of sALCAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean intraocular pressure (IOP) at 6 and 12 hours post-surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Morphine use in the Postanesthesia Care Unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay for first analgesic demand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean rectal MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: S-RS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Joint effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lysholm scale scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Inhibition of crystal growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number and size of crystals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of crystal nucleation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent adequate compression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent adequate depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent total hands-off time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global pain catastrophising
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain acceptance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: global function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: perceived stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical functioning difficulties
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in suicidal ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of IOP-lowering medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete surgical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of chyle leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of siderophilin, prealbumin, CD4/CD8, GH, IGF-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: level of urea nitrogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: level of albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean plasma ghrelin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: ST depression at bicycle exercise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of complete healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients having a 90% reduction in ulcer surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to onset of the first 24-h heartburn-free period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean number of heartburn-free days by D7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall quality of pain relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weight gain in neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken for transition to breast feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of hospital stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prostate specific antigen values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Continuation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative gross rate for pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Total expulsion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean maternal weight gain during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Lavage fluid levels of alpha 2‐macroglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lavage fluid levels of tryptase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma concentrations of π‐methylhistidine (π‐M‐His)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean therapeutic score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean teamwork score
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Reduction in glycated haemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Annualized rate of nocturnal confirmed or severe hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in BASDAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C reactive protein (CRP) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Forced pulmonary vital capacity (FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Repositioning frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased NSSI frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF‐α values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Two-year postoperative improvement in Oswestry Disability Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean improvement in Short Form‐36 physical component score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean fusion grade on computed tomography scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Alveolar-arterial PO2 difference (AaDO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Type and frequency of acute complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of STI diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: pulse oximetry oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: safety and effectiveness of pain palliation
Endpoint domain: Adverse events/effects
Primary endpoint: Achievement of treatment and educational goals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: quality of life (QLQ-C30 score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Need for postoperative supplementary analgesics
Endpoint domain: Adverse events/effects
Primary endpoint: affective response
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Low adherence to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vascular inflammation measured by (18)F‐fluorodeoxyglucose uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: physician-assessed moderate/marked adverse effects in the breast
Endpoint domain: Adverse events/effects